ArticleOncotarget2016

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.

Michele Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.